Publications by authors named "Yu Kumazaki"

Claim this Profile
C
Characteristics of cardiac toxicity after definitive radiation therapy for thoracic esophageal cancer in Japanese patients.
Keita Tsukahara, Takanori Abe, Satoshi Saito, Takumi Sakaguchi, Jun Watanabe, Yu Kumazaki

J Radiat Res· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stereotactic body radiotherapy with CyberKnife for liver-confined hepatocellular carcinoma: systematic review and meta-analysis.
Takanori Abe, Mototaro Iwanaga, Mitsunobu Igari, Ryuta Hirai, Yu Kumazaki

J Radiat Res· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Japanese national survey on IMRT/SBRT in 2023 by the JASTRO High-Precision External Beam Radiotherapy Group.
Masahide Saito, Shuichi Ozawa, Takafumi Komiyama, Masaki Kokubo, Yoshiyuki Shioyama, Yu Kumazaki

J Radiat Res· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stereotactic Body Radiotherapy Using CyberKnife for Metastatic Liver Tumors: A Single-center Retrospective Study.
Yasuhiro Ryuno, Takanori Abe, Keita Tsukahara, Jun Watanabe, Misaki Iino, Y U Kumazaki

Anticancer Res· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[6. Commissioning and Dosimetry Standards for 0.35 Tesla MRI Linac].
Yu Kumazaki

Nihon Hoshasen Gijutsu Gakkai Zasshi· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Results of Definitive (Chemo)radiotherapy Using Computed Tomography-based Brachytherapy for Cervical Cancer.
Tomomi Aoshika, Shin-Ei Noda, Takanori Abe, Y U Kumazaki, Ryuta Hirai

Anticancer Res· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Learning curve of lung dose optimization in intensity-modulated radiotherapy for locally advanced non-small cell lung cancer.
Mitsunobu Igari, Takanori Abe, Misaki Iino, Satoshi Saito, Tomomi Aoshika, Yu Kumazaki

Thorac Cancer· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimal Number of Needle Applicators Inserted in Combined Intracavitary and Interstitial Brachytherapy for Cervical Cancer.
Ryuta Hirai, Tomohiro Ohta, Mitsunobu Igari, Y U Kumazaki, Misaki Iino

Anticancer Res· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A virtual audit system for intensity-modulated radiation therapy credentialing in Japan Clinical Oncology Group clinical trials: A pilot study.
Mitsuhiro Nakamura, Dejun Zhou, Toshiyuki Minemura, Satoshi Kito, Hiroyuki Okamoto, Yu Kumazaki

J Appl Clin Med Phys· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of the Efficacy and Toxicity of Concurrent Chemoradiotherapy and Durvalumab and Concurrent Chemoradiotherapy Alone for Locally Advanced Non-small Cell Lung Cancer With N3 Lymph Node Metastasis.
Takanori Abe, Misaki Iino, Satoshi Saito, Tomomi Aoshika, Yasuhiro Ryuno, Y U Kumazaki

Anticancer Res· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multi-Institutional Study of End-to-End Dose Delivery Quality Assurance Testing for Image-Guided Brachytherapy Using a Gel Dosimeter.
Hidenobu Tachibana, Yusuke Watanabe, Shogo Kurokawa, Takuya Maeyama, Tomoyuki Hiroki, Yu Kumazaki

Brachytherapy· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Results of computer tomography-based adaptive brachytherapy in combination with whole-pelvic- and central-shielding-external beam radiotherapy for cervical cancer.
Tomomi Aoshika, Shin-Ei Noda, Takanori Abe, Yu Kumazaki, Ryuta Hirai

Brachytherapy· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Efficacy of Palliative Radiotherapy (25 Gy × 5 Fractions) for Symptomatic Pelvic Tumors.
Tomomi Aoshika, Takanori Abe, Misaki Iino, Satoshi Saito, Yasuhiro Ryuno, Y U Kumazaki

Anticancer Res· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of using a gamma index analysis for patient-specific quality assurance in Japan.
Yusuke Anetai, Iori Sumida, Yu Kumazaki, Satoshi Kito, Masahiko Kurooka

J Appl Clin Med Phys· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Simple method for evaluating achievement degree of lung dose optimization in individual patients with locally advanced non-small cell lung cancer treated with intensity modulated radiotherapy.
Takanori Abe, Misaki Iino, Satoshi Saito, Tomomi Aoshika, Yasuhiro Ryuno, Yu Kumazaki

Thorac Cancer· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Practical guidelines of online MR-guided adaptive radiotherapy.
Hiroyuki Okamoto, Hiroshi Igaki, Takahito Chiba, Keiko Shibuya, Tatsuya Sakasai, Yu Kumazaki

J Radiat Res· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Japanese prospective multi-institutional feasibility study on accelerated partial breast irradiation using multicatheter interstitial brachytherapy: clinical results with a median follow-up of 60 months.
Ken Yoshida, Takayuki Nose, Yuki Otani, Shuuji Asahi, Iwao Tsukiyama, Yu Kumazaki

Breast Cancer· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-dose stereotactic body radiotherapy using CyberKnife® for stage I peripheral lung cancer: a single-center retrospective study.
Yasuhiro Ryuno, Takanori Abe, Misaki Iino, Satoshi Saito, Tomomi Aoshika, Yu Kumazaki

Radiat Oncol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A 54 Gy in three fractions of stereotactic body radiotherapy using CyberKnife for T1b-2aN0M0 pathologically confirmed non-small cell lung cancer.
Takanori Abe, Yasuhiro Ryuno, Misaki Iino, Satoshi Saito, Tomomi Aoshika, Yu Kumazaki

Jpn J Clin Oncol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feasibility of intensity modulated radiotherapy with involved field radiotherapy for Japanese patients with locally advanced non-small cell lung cancer.
Takanori Abe, Misaki Iino, Satoshi Saito, Tomomi Aoshika, Yasuhiro Ryuno, Yu Kumazaki

J Radiat Res· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence and risk factors for pneumonitis among patients with lung cancer who received immune checkpoint inhibitors after palliative thoracic radiotherapy.
Satoshi Saito, Takanori Abe, Misaki Iino, Tomomi Aoshika, Yasuhiro Ryuno, Yu Kumazaki

J Radiat Res· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plan-Optimization Method for Central-shielding Pelvic Volumetric-modulated Arc Therapy for Cervical Cancer.
Ryuta Hirai, Tomoaki Tamaki, Mitsunobu Igari, Y U Kumazaki, Shin-Ei Noda

In Vivo· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Time Dependence of Intra-fractional Motion in Spinal Stereotactic Body Radiotherapy.
Ryuta Hirai, Y U Ohkubo, Mitsunobu Igari, Y U Kumazaki, Tomomi Aoshika

In Vivo· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Results of definitive radiotherapy with concurrent chemotherapy for maxillary sinus carcinomas with neck lymph node metastasis.
Takanori Abe, Satoshi Saito, Misaki Iino, Tomomi Aoshika, Yasuhiro Ryuno, Yu Kumazaki

J Radiat Res· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of durvalumab on local control after concurrent chemoradiotherapy for locally advanced non-small cell lung cancer in comparison with chemoradiotherapy alone.
Takanori Abe, Satoshi Saito, Misaki Iino, Tomomi Aoshika, Yasuhiro Ryuno, Yu Kumazaki

Thorac Cancer· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis